echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Puli Pharmaceutical's desloratadine dry suspension passed the EU technical review

    Puli Pharmaceutical's desloratadine dry suspension passed the EU technical review

    • Last Update: 2021-10-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On August 23, Hainan Puli Pharmaceuticals issued an announcement stating that the company recently received an End of Procedure from the European Commission for the Evaluation of Drugs (CBG), which means that the company’s desloratadine dry suspension The drug has successfully passed the review by the Dutch Drug Evaluation Board (CBG) and the German Federal Agency for Drugs and Medical Devices (BfArM), and will soon be approved for marketing in the Netherlands and Germany
    .

    Deloratadine is a non-sedative, long-acting tricyclic antihistamine, and is the active metabolite of loratadine.
    It can selectively block peripheral H1 receptors and inhibit various allergic inflammations.
    The release of chemical media can be used to relieve allergic rhinitis and urticaria related symptoms in adults, adolescents 12 years and older, and children 6-11 years old
    .

    Desloratadine was developed by Sepracor, Schering-Plough, and listed in 53 countries around the world
    .


    The 2.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.